Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Deferred Taxes: 2024

Historic Deferred Taxes for Adma Biologics (ADMA) over the last 1 years, with Dec 2024 value amounting to $84.3 million.

  • Adma Biologics' Deferred Taxes was N/A to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.1 million, marking a year-over-year change of. This contributed to the annual value of $84.3 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Adma Biologics reported Deferred Taxes of $84.3 million as of FY2024.
  • Adma Biologics' Deferred Taxes' 5-year high stood at $84.3 million during FY2024, with a 5-year trough of $84.3 million in FY2024.
  • Moreover, its 1-year median value for Deferred Taxes was $84.3 million (2024), whereas its average is $84.3 million.